Resource Provides Information on Out-of-Control Drug Prices — Outlines Bipartisan, Market-Based Solutions to Hold Big Pharma Accountable and Deliver Relief for American Patients
For Immediate Release
Contact: Jon Conradi
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a briefing packet Monday for Members of Congress that aims to provide lawmakers, their staff and stakeholders critical information on out-of-control prescription drug prices and outline bipartisan, market-based solutions to hold brand name manufacturers accountable and deliver relief for American patients.
“Out-of-control drug prices are one of the biggest challenges facing our nation today,” CSRxP executive director Lauren Aronson writes in the packet. “Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the economic impact of the crisis continues to leave millions of American workers, families and seniors struggling just to stay afloat. Meanwhile, prescription drug prices continue to rise, making it harder and harder for American patients to afford their medications at the most challenging of moments: in the midst of America’s battle against the pandemic.”
“Members of Congress have a rare opportunity to convert their campaign promises into substantive bipartisan action, upending the status quo with reforms that hold drug companies accountable and deliver relief for American patients,” Aronson continues. “We wanted to provide you with a resource that further explains why drug prices have become so out-of-control and what lawmakers can do to reverse this trend and dramatically improve the lives of patients in their districts through: 1) aggressive oversight of drug makers and 2) bipartisan, market-based reforms that boost competition, strengthen transparency and encourage innovation. CSRxP looks forward to working with you to tackle this important issue and make prescription drugs more affordable for all Americans.”
Read the full briefing packet HERE.
CSRxP is a broad-based coalition of leaders – physicians, nurses, hospitals, consumers, health plans, PBMs, pharmacists, and businesses – promoting bipartisan, market-based solutions to lower drug prices in America.
Learn more about CSRxP and its mission HERE.